Further study has demonstrated that TIM-3 is expressed on endothelial cells, but in this context, it does not function as a Gal-9 receptor but rather interacts with melanoma cells to trigger the NF-κB signaling pathway, promoting cell proliferation and reducing the apoptosis rate [62]. Here, HAVCR2 is linked to melanoma.